The firm has secured rights to use CRISPR in cell lines for biomanufacturing and will work with Solentim to increase editing throughput while decreasing costs.
The partners plan to develop a computational platform that automates pipelines and processes for biomarker discovery, drug recovery and repositioning, and more.
NEW YORK (GenomeWeb) – Horizon Discovery Group today announced it and life sciences measurement and testing firm LGC have received a £360,224 ($612,000) research grant to develop novel reference standard materials for clinical diagnostics.
NEW YORK (GenomeWeb News) – The UK government and economic development organizations in Scotland and Northern Ireland plan to invest up to £2.8 million ($4.6 million) to fund small businesses pursuing feasibility research projects, including those involving various omics and bioinformatics techno
NEW YORK (GenomeWeb News) – Enigma Diagnostics today announced a second grant from the UK's Technology Strategy Board to further develop the company's multidrug-resistant tuberculosis (MDR-TB) test on its Enigma Mini Laboratory system.
NEW YORK (GenomeWeb News) – Several UK government bodies plan to award up to £3.8 million ($6.1 million) in competitive grants to fund industry-led research and development projects to advance synthetic biology technologies, according to the Biotechnology and Biological Sciences Research Council.
NEW YORK (GenomeWeb News) – QuantuMDx said today that it has received a £1 million ($1.6 million) grant from the UK government's Technology Strategy Board to fund a project to develop a rapid test for multi-drug resistant tuberculosis.
